Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Optical coherence tomography (OCT) is an imaging technique which shows the internal structure of living tissue (in vivo). It is safe, quick and painless to perform, and does not damage the tissue in any way. Recent advances in the technology mean that it can now be used to take images of the internal structure of the skin. This is useful because certain conditions, such as skin cancers, alter this structure. At present a suspected skin cancer is identified by taking a sample (a biopsy) which is analysed under the microscope to confirm the diagnosis. The cancer is then excised including a margin of apparently healthy-looking skin around it to ensure that the entirety of the tumour is removed. The excised tumour is then analysed again under a microscope to confirm that it was indeed completely removed (histology), after which a further operation is required to repair the defect.
The purpose of this study is to evaluate OCT imaging of a particular type of skin cancer called a basal cell carcinoma (BCC), and in particular BCCs affecting the skin around the eyes (periocular). The study will compare the ability of OCT to define the margin of the BCC with the current 'gold standard' of histology. OCT could potentially improve the investigators ability to define the margins of the tumour before surgery and become a guide for minimally invasive surgery. The preservation of healthy tissue represents a priority, particularly in the area of the skin surrounding the eye.
| Condition | Intervention |
|---|---|
|
Basal Cell Carcinoma |
Other: OCT |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | An Investigation of the Correlation Between OCT and Histology in Defining the Margins of Periocular Basal Cell Carcinoma |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
BCC
Adult of any age or gender with capacity to give informed consent who has a basal cell carinoma requiring surgical excision and involving the periocular skin
|
Other: OCT
Optical coherence tomography of periocular basal cell carcinoma
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Adults with periocular basal cell carcinoma
Inclusion Criteria:
- Adults of any age or gender who have capacity to give informed consent, and who have periocular basal cell carcinoma requiring surgical excision
Exclusion Criteria:
- Children, vulnerable adults, inability to give informed consent
Contacts and Locations| United Kingdom | |
| Maidstone Hospital | Not yet recruiting |
| Maidstone, Kent, United Kingdom, ME16 9QQ | |
| Contact: Henry B Smith, FRCOphth 01622226255 hbs@doctors.net.uk | |
| Principal Investigator: | Henry B Smith, FRCOphth | Maidstone & Tunbridge Wells NHS Trust |
More Information
No publications provided
| Responsible Party: | Henry Smith, Oculoplastics Fellow, Maidstone & Tunbridge Wells NHS Trust |
| ClinicalTrials.gov Identifier: | NCT01603810 History of Changes |
| Other Study ID Numbers: | MTW001 |
| Study First Received: | May 19, 2012 |
| Last Updated: | May 21, 2012 |
| Health Authority: | United Kingdom: Research Ethics Committee United States: Federal Government |
Keywords provided by Maidstone & Tunbridge Wells NHS Trust:
|
Basal cell carcinoma Optical Coherence Tomography |
Additional relevant MeSH terms:
|
Carcinoma Carcinoma, Basal Cell Neoplasms, Glandular and Epithelial |
Neoplasms by Histologic Type Neoplasms Neoplasms, Basal Cell |
ClinicalTrials.gov processed this record on June 17, 2013